Dominick Angiolillo

CHIEF & DIS PROF

JX-MEDICINE AT JAX

  • CHIEF & DIS PROF
    JX-MEDICINE AT JAX

GRANTS

  • GRANT
    GEM Platelet Aspirin Test Cartridge External Precision Protocol
    Werfen-Instrumentation5 May 2026 - 4 May 2027
    Active
  • GRANT
    GEM Platelet PRUTest Cartridge External Precision Protocol
    Werfen-Instrumentation3 Mar 2026 - 2 Mar 2027
    Active
  • GRANT
    Randomized study for double-blind, placebo-controlled evaluation of a single intravenous infusion of BI 765845 and partially-blinded evaluation of a single bolus administration of BI 765845 on top of standard of care in patients with acute myocardial infarction
    Boehringer Ingelheim Pharm Inc7 Mar 2025 - 8 Mar 2025
    Expired
  • GRANT
    T-TAS® wS Method Comparison
    Hikari Dx18 Nov 2024 - 31 Mar 2025
    Expired
  • GRANT
    Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Adult and Pediatric Subjects With APOL1-mediated Proteinuric Kidney Disease
    Vertex Pharmaceuticals25 Oct 2024 - 24 Oct 2029
    Active
  • GRANT
    A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Adult Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications
    Alnylam Pharmaceuticals19 Sep 2024 - 20 Feb 2025
    Closed
  • GRANT
    A phase III, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in a genetically defined population with a recent Acute Coronary Syndrome (ACS)
    Dalcor Pharmaceuticals8 Mar 2024 - 8 Mar 2029
    Active
  • GRANT
    Revascularization Choices Among under-Represented Groups Evaluation (The Recharge Trial)
    Patient-Centered Outcomes Research Institute1 Mar 2024 - 1 Mar 2029
    Active
  • GRANT
    A randomized, placebo-controlled, parallel-group, investigator- and participant-blinded Phase 2a study to investigate the efficacy, safety, and tolerability of DFV890 for inflammatory marker reduction in adult participants with coronary heart disease and elevated hsCRP
    Novartis Pharmaceuticals Corporation27 Oct 2023 - 21 Aug 2025
    Expired
  • GRANT
    Care4Today Study
    Janssen Research and Development27 Sep 2023 - 5 Sep 2024
    Closed
  • GRANT
    IOCYTE AMI-3: A randomized, double-blind, placebo-controlled, multicenter study of intravenous FDY-5301 in subjects with an anterior ST-elevation myocardial infarction
    Faraday Pharmaceuticals2 Aug 2023 - 17 Nov 2025
    Closed
  • GRANT
    Medtronic Electrophysiology Fellowship Grant 2024
    1 Jul 2023 - 30 Jun 2024
    Expired
  • GRANT
    One-month DAPT In CABG PatieNts: the ODIN trial
    Canadian Institutes of Health Research1 Apr 2023 - 31 Mar 2030
    People funded by this grant:
    • Gaudino M,
    • Redfors B,
    • Ruel M,
    • Sandner S,
    • Angiolillo D
  • GRANT
    Canadian Institutes of Health Research1 Apr 2023 - 31 Mar 2030
    People funded by this grant:
    • Wells GA,
    • Fremes SE,
    • Voisine P,
    • Noiseux N,
    • Farkouh ME
  • GRANT
    Assessment of Individual Risk of Cardiovascular Events by Platelet FcGammaRIIa
    Prolocor18 Apr 2022 - 13 May 2025
    Expired
  • GRANT
    A Study of Contrast-induced Acute Kidney Injury Prediction Using the RENISCHEM L-FABP Assay at the Point-of-Care (SAKURA-POC)
    Hikari Dx15 Nov 2021 - 11 May 2026
    Expired
  • GRANT
    UFF Scott R. MacKenzie Foundation Grant
    Scott R Mackenzie Foundation1 Jan 2021 - 2 Jan 2021
    Expired
  • GRANT
    Impact of Timing of Pharmacodynamic Assessments on Measures of Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention Treated with Cangrelor
    Chiesi USA30 Nov 2020 - 30 Nov 2025
    Closed
  • GRANT
    Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests with Investigational Reagent to Reagents Registered in Japan
    Accriva Diagnostics20 Oct 2020 - 9 Sep 2022
    Closed
  • GRANT
    Precision antiplatelet therapy after percutaneous coronary intervention
    National Institute of Health Nhlbi15 Jun 2020 - 30 Jun 2026
    Expired
  • GRANT
    Evaluating Fitness-for-use of Electronic Health Records in Clinical Research
    US Food and Drug Administration9 Jun 2020 - 29 Sep 2022
    Expired
  • GRANT
    UFF Scott R. MacKenzie Foundation Grant
    Scott R Mackenzie Foundation1 Jan 2020 - 31 Dec 2021
    Expired
  • GRANT
    Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
    Chiesi USA31 Oct 2019 - 15 Sep 2026
    Active
  • GRANT
    A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke.
    Amgen Inc29 Aug 2019 - 1 Aug 2026
    Expired
  • GRANT
    Early Feasibility Study of the Edwards Transcatheter Atrial Shunt System
    Edwards Lifesciences16 Aug 2019 - 15 Sep 2026
    Active